Financing ·
Glucotrack, Inc. entered into an Exchange Agreement on July 22, 2026, to partition a new $900,000 promissory note from…
GCTKGlucotrack, Inc.
Glucotrack, Inc. entered into an Exchange Agreement on July 22, 2026, to partition a new $900,000 promissory note from an existing debt obligation. The agreement allows the investor to exchange the partitioned note for common stock at a price based on the lower of the Nasdaq closing price or a five-day average. The transaction involves no cash consideration and is subject to a 9.99% beneficial ownership limitation. Glucotrack, Inc. develops medical technology for glucose monitoring and metabolic health management.